All In Biotech

Drug Trial Radar · NCT05358886

A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome

A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome

Last checked: Nov 19, 2026Latest source record: Jul 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 171 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

171

Actual

Start

Nov 1, 2022

Primary completion

Jul 18, 2025

Study completion Jul 18, 2025

Sponsor

Lead sponsor
Tetra Discovery PartnersIndustry
Sponsor type
Industry
First posted
May 3, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Male only, from 18 years, up to 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of BPN14770 in Male Adults (Aged 18 to 45) with Fragile X Syndrome

Conditions

  • Fragile X Syndrome

Interventions

  • BPN14770/ zatolmilastDrug

    25mg BID BPN14770

  • PlaceboDrug

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. National Institutes of Health Toolbox Cognitive Battery cognition crystallized composite score (NIH-TCB CCC)Time frame: 13 Weeks

Locations

17 sites in 1 country. Site status is shown where the registry gives one.

  • Amnova Clinical Research

    Irvine, California

  • Thompson Autism & Neurodevelopment Center - CHOC

    Orange, California

  • UC Davis Health System

    Sacramento, California

  • Children's Hospital Colorado

    Aurora, Colorado

  • University of Miami

    Miami, Florida

  • Emory University School of Medicine

    Atlanta, Georgia

  • Rush University Medical Center

    Chicago, Illinois

  • University of Kansas Medical Center

    Kansas City, Kansas

  • Kennedy Krieger Institute

    Baltimore, Maryland

  • Boston Children's Hospital

    Boston, Massachusetts

  • University of Massachusetts Medical School

    Worcester, Massachusetts

  • Icahn School of Medicine at Mount Sinai Hospital

    New York, New York

  • Cincinnati Childrens Hospital Medical Center

    Cincinnati, Ohio

  • Suburban Research Associates

    Media, Pennsylvania

  • Clinic for Special Children

    Strasburg, Pennsylvania

  • Greenwood Genetic Center

    Greenville, South Carolina

  • University of Utah and Primary Childrens Hospital

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.